Management – DiagnosTear

Nimrod Bin-Nun

CEO DiagnosTear

Mr. Nimrod Bin-Nun has an extensive experience in global Pharma, Medical Devices and Diagnostics companies. Prior to his CEO position in DiagnosTear Mr. Bin-Nun worked in BioLight as a business development director, leading the business development activity of the group and supporting BioLight portfolio companies.

Previously, Mr. Bin-Nun worked at Teva Pharmaceuticals for 6 years in both finance and business development, mostly focusing on the Asian markets.

Nimrod holds a dual-BA/B.Sc. in Economics and Biology and an MBA in Finance and Marketing, both from Tel Aviv University.

Dr. Eran Eilat

CMO DiagnosTear

Dr. Eran Eilat

M.D, Ph.D,
A serial entrepreneur who has founded several biotechnology and medical device companies including, Otic Pharma, a developer of  unique drug delivery technology for delivering drugs to the ears, which completed a successful phase II clinical trial, and closed a significant financing round led by Orbimed, and AOPharma, which has developed a proprietary preservative free, multi-dose and user-friendly ophthalmic drug delivery device. Dr. Eilat received an M.D. degree from the Sackler School of Medicine in Tel Aviv University, and a Ph.D. degree in Immunology from the Weizmann Institute of Science. He is the inventor of numerous patents in the medical and biotechnology fields.